There are 1105 resources available
447P - Evaluating the efficacy and safety of pembrolizumab in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter, retrospective study analysis
Presenter: Man Hu
Session: Poster Display session
Resources:
Abstract
448P - Linking VEGF-A expression and genetic alterations to survival in oral squamous cell carcinoma
Presenter: Benish Aleem
Session: Poster Display session
Resources:
Abstract
449P - Identification and validation of a novel m6A modulator LRPPRC signature associated with oral squamous cell carcinoma
Presenter: Karpaka Vinayakam Gopalakrishnan
Session: Poster Display session
Resources:
Abstract
450P - Dysregulated expression of replication factor C subunit 5 (RFC5) serves as a potential biomarker for head and neck squamous cell carcinoma
Presenter: Anitha Pandi
Session: Poster Display session
Resources:
Abstract
451P - Identification of a biomarker compendium for different clinical stages of oral submucous fibrosis by second gel electrophoresis and mass spectrometry along with validations: A first Indian experience
Presenter: Yasasve Madhavan
Session: Poster Display session
Resources:
Abstract
452P - Characteristics and treatment patterns of patients diagnosed with nasopharyngeal carcinoma in Indonesia: A descriptive study using the National Health Insurance database
Presenter: Susanna Hutajulu
Session: Poster Display session
Resources:
Abstract
453P - Cross-resistance of head and neck squamous cell cancer cells to cetuximab and radiation
Presenter: James A. Bonner
Session: Poster Display session
Resources:
Abstract
454P - Institutional experience of concurrent Doce-aquilip in head and neck cancer patients who are cisplatin ineligible
Presenter: Vansh Arora
Session: Poster Display session
Resources:
Abstract
455P - A real-world study: Induction chemoimmunotherapy versus induction chemotherapy followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with stage IVa
Presenter: Kunpeng Wu
Session: Poster Display session
Resources:
Abstract
456P - Real-world analysis of usage and efficacy of immune check point inhibitors in recurrent/metastatic head and neck cancers
Presenter: Kshitij Domadia
Session: Poster Display session
Resources:
Abstract